These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15561482)

  • 1. Preliminary evidence of an association between childhood abuse and cannabis dependence among African American first-episode schizophrenia-spectrum disorder patients.
    Compton MT; Furman AC; Kaslow NJ
    Drug Alcohol Depend; 2004 Dec; 76(3):311-6. PubMed ID: 15561482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample.
    Compton MT; Furman AC; Kaslow NJ
    Schizophr Res; 2004 Nov; 71(1):61-4. PubMed ID: 15374573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study.
    Abajobir AA; Najman JM; Williams G; Strathearn L; Clavarino A; Kisely S
    Psychiatry Res; 2017 Oct; 256():21-31. PubMed ID: 28622571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates of maltreatment and traumatic experiences in childhood and adolescence among predominantly African American, socially disadvantaged, hospitalized, first-episode psychosis patients.
    Ramsay CE; Flanagan P; Gantt S; Broussard B; Compton MT
    Psychiatry Res; 2011 Aug; 188(3):343-9. PubMed ID: 21665293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.
    Malchow B; Hasan A; Fusar-Poli P; Schmitt A; Falkai P; Wobrock T
    Eur Arch Psychiatry Clin Neurosci; 2013 Feb; 263(1):3-13. PubMed ID: 22907121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between cannabis abuse and dependence and childhood physical and sexual abuse: evidence from an offspring of twins design.
    Duncan AE; Sartor CE; Scherrer JF; Grant JD; Heath AC; Nelson EC; Jacob T; Bucholz KK
    Addiction; 2008 Jun; 103(6):990-7. PubMed ID: 18482422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.
    Miller R; Ream G; McCormack J; Gunduz-Bruce H; Sevy S; Robinson D
    Schizophr Res; 2009 Sep; 113(2-3):138-44. PubMed ID: 19481424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
    Hall W; Degenhardt L
    BMJ; 2015 Mar; 350():h1205. PubMed ID: 25739398
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabis use and age at onset of schizophrenia.
    Veen ND; Selten JP; van der Tweel I; Feller WG; Hoek HW; Kahn RS
    Am J Psychiatry; 2004 Mar; 161(3):501-6. PubMed ID: 14992976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
    Dubertret C; Bidard I; Adès J; Gorwood P
    Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women.
    Werner KB; McCutcheon VV; Agrawal A; Sartor CE; Nelson EC; Heath AC; Bucholz KK
    Drug Alcohol Depend; 2016 May; 162():162-9. PubMed ID: 27012434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental pathways to adolescent cannabis abuse and dependence: child maltreatment, emerging personality, and internalizing versus externalizing psychopathology.
    Oshri A; Rogosch FA; Burnette ML; Cicchetti D
    Psychol Addict Behav; 2011 Dec; 25(4):634-44. PubMed ID: 21534646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less self-stigmatization and more empowerment in patients with schizophrenia and comorbid cannabis use disorder compared to non-comorbid schizophrenia.
    Schnell T; Moritz S
    Schizophr Res; 2020 Aug; 222():523-524. PubMed ID: 32507374
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.
    Koskinen J; Löhönen J; Koponen H; Isohanni M; Miettunen J
    Schizophr Bull; 2010 Nov; 36(6):1115-30. PubMed ID: 19386576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.